Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
For pregnant women with lupus, continuing hydroxychloroquine lowers flare risk and appears safe for the baby. It may also reduce the risk of congenital heart block in anti-Ro-positive mothers.
Hydroxychloroquine, chloroquine, and primaquine all carry warnings for G6PD deficiency, but their actual hemolysis risk differs sharply by chemistry and dose.
Hydroxychloroquine fights malaria and calms lupus through the same basic trick: making acidic cellular compartments less acidic.
How a bark-derived remedy from the Andes led to two related drugs, and why parasite resistance—not hydroxychloroquine—became malaria's real challenge.
Why hydroxychloroquine takes months to work and months to leave the body—and how its unusual pharmacokinetics shape dosing in lupus and rheumatoid arthritis.
Hydroxychloroquine can slowly damage the retina after years of use. Here's what the evidence shows about who is most at risk and why regular eye exams matter.
Hydroxychloroquine and praziquantel are unrelated drugs treating unrelated conditions. This article explains their distinct mechanisms, approved uses, and why comparing them directly is usually a category error.
Hydroxychloroquine and mebendazole treat entirely different conditions through unrelated mechanisms. Here is how each actually works, and what to know if both appear on the same medicine cabinet shelf.
Hydroxychloroquine and doxycycline are unrelated drugs from different classes, occasionally confused because both appear in malaria and infection care.